Page last updated: 2024-10-24

chelerythrine and B16 Melanoma

chelerythrine has been researched along with B16 Melanoma in 1 studies

chelerythrine : A benzophenanthridine alkaloid isolated from the root of Zanthoxylum simulans, Chelidonium majus L., and other Papaveraceae.

Research Excerpts

ExcerptRelevanceReference
"Oral treatment with sanguinarine reduced the tumor burden in a transplantable murine tumor grown in a syngeneic host (B16 melanoma 4A5 in C57BL/6 mice), and in a human tumor xenograft grown in immunodeficient mice (A375 human melanoma in athymic nude mice)."1.35Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma. ( De Stefano, I; Ferlini, C; Gallo, D; Mosca, M; Prisco, MG; Raspaglio, G; Scambia, G; Travaglia, D; Zannoni, GF, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Stefano, I1
Raspaglio, G1
Zannoni, GF1
Travaglia, D1
Prisco, MG1
Mosca, M1
Ferlini, C1
Scambia, G1
Gallo, D1

Other Studies

1 other study available for chelerythrine and B16 Melanoma

ArticleYear
Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma.
    Biochemical pharmacology, 2009, Dec-01, Volume: 78, Issue:11

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Benzophenanthridines; Cell Line, Tumor; Cel

2009